Journal - Endocrine, Metabolic & Immune Disorders - Drug Targets

Impact Factor

Current: 2.895
5 - Year: 3.037

Ranking & Category

110th of 143 in Endocrinology & Metabolism
126th of 155 in Immunology
172nd of 261 in Pharmacology & Pharmacy

Topic(s) Covered

2 Topic(s)

View

Covered Disease(s)

1 Disease(s)

View

Aims & Scope

This journal is devoted to full-length/ mini-reviews and original articles based on experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to the effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbiome composition are welcome. The journal’s scope also covers neuroendocrinology, reproductive endocrinology, hormone secretion, and their effects on different organs.

Abstracted/Indexed in

BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Dimensions, EBSCO, EMBASE/Excerpta Medica, ERA 2018, Genamics, JournalSeek, Google Scholar, InCites, J-Gate, JournalTOCs, MediaFinder®-Standard Periodical Directory, MEDLINE/PubMed/Index Medicus, Open Abstracts (I4OA), Norwegian Register, PubsHub, QOAM Science Citation Index Expanded™ (SciSearch®), Scilit, Scopus, Suweco CZ, TOC Premier, and Ulrich's Periodicals Directory.

COPE COMPLIANT

Special Offers

New eBook

Immune Response to Parasitic Infections: Immunity to Helminths and Novel Therapeutic Approaches
You can view the contents of this
eBook [here] .

Endorsement(s)

"EMID-DT is a prestigious journal with a multidisciplinary coverage. Its aim is to provide cutting- edge information to readers working in different field of research ranging from immune endocrine to metabolic disorders."

Chris Galanos
Max Planck Institude, Germany

Authors' Comments

Thank you for your email. Our experience of publishing with Endocrine, Metabolic and Immune Disorders - Drug Targets has been pleasant and smooth. The reports from peer reviewers arrived within a reasonable time frame and their comments were most constructive and helpful. The editors are meticulous and responsive. We hope to publish with your esteemed journal again in the near future.

Kok Yong Chin
(Department of Pharmacology/Bone Metabolism Research Group, Universiti Kebangsaan Malaysia Medical Centre.)

Has contributed: A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer.